Search

everythinglearnresearchcommunity

for

Search:↓

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Oral JAK inhibitors effectively treat alopecia areata and are generally well-tolerated.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

17β-estradiol can reduce inflammation in the skin.

The molecule Wise is involved in the development of various structures in chick embryos.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Dutasteride and finasteride can help increase hair growth gene expression but need further improvement.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Ellagic acid may help regrow hair and prevent hair loss by activating a specific cell growth pathway.

Entospletinib effectively prevents eye and skin GVHD in mice.

A new method using Y-27632 improves the growth and quality of human hair follicle stem cells for tissue engineering and therapy.

Three natural compounds from Ghanaian plants may help treat BPH and alopecia.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

The new compound may be a safer alternative to finasteride for prostate protection.

Farudodstat may help prevent hair loss in alopecia areata by stopping immune attacks on hair follicles.

Farudodstat can prevent hair follicle immune damage linked to alopecia areata.

New compounds show promise as nonsteroidal treatments for hair loss.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Wedelolactone may help prevent bone damage in breast cancer by blocking certain cell signals.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Glibenclamide slows breast cancer cell growth by stopping cell division.

ICAM-1 helps regulate hair growth cycles and skin remodeling.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Finasteride harms Daphnia magna's reproduction, growth, and metabolism.

The new method provides more accurate vibrational frequencies for drug molecules than traditional models.

miR-29a-5p prevents the formation of early hair structures by targeting a gene important for hair growth and is regulated by a complex network involving lncRNA627.1.

Lambertianic acid helps prevent muscle wasting.